<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">zabmedvestnik</journal-id><journal-title-group><journal-title xml:lang="ru">Забайкальский медицинский вестник</journal-title><trans-title-group xml:lang="en"><trans-title>Transbaikalian Medical Bulletin</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">1998-6173</issn><publisher><publisher-name>Читинская государственная медицинская академия</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.52485/19986173_2025_4_10</article-id><article-id custom-type="elpub" pub-id-type="custom">zabmedvestnik-519</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>ДИАГНОСТИЧЕСКАЯ ЗНАЧИМОСТЬ НЕЙТРОФИЛЬНО-ЛИМФОЦИТАРНОГО И ТРОМБОЦИТАРНО-ЛИМФОЦИТАРНОГО СООТНОШЕНИЯ ДЛЯ ПРОГНОЗИРОВАНИЯ ТЯЖЕСТИ РОТАВИРУСНОГО ГАСТРОЭНТЕРИТА У ДЕТЕЙ</article-title><trans-title-group xml:lang="en"><trans-title>THE PREDICTIVE VALUE OF NEUTROPHIL-TO-LYMPHOCYTE AND PLATELET-TOLYMPHOCYTE RATIOS FOR ASSESSING SEVERITY OF ROTAVIRUS GASTROENTERITIS IN CHILDREN</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8389-8730</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Андреева</surname><given-names>Е. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Andreeva</surname><given-names>E. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Андреева Елена Владимировна, к.м.н., доцент кафедры поликлинической педиатрии с курсом медицинской реабилитации </p><p>672000, г. Чита, ул. Горького, 39а</p></bio><bio xml:lang="en"><p>Andreeva E.V., Candidate of Medical Sciences, Associate Professor of the Department of Polyclinic Pediatrics, with acourse in Medical Rehabilitation </p><p>39a Gorky St., Chita, 672000</p></bio><email xlink:type="simple">drelena11@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2109-4643</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мироманова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Miromanova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Мироманова Наталья Анатольевна, д.м.н., доцент, заведующая кафедры детских инфекционных болезней </p><p>672000, г. Чита, ул. Горького, 39а</p></bio><bio xml:lang="en"><p>Miromanova N.A., Doctor of Medical Sciences, Associate Professor, Head of the Department of Children's Infectious Diseases </p><p>39a Gorky St., Chita, 672000</p></bio><email xlink:type="simple">detinf-chita@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Читинская государственная медицинская академия» Министерства здравоохранения РФ</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Chita State Medical Academy</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>19</day><month>02</month><year>2026</year></pub-date><volume>0</volume><issue>4</issue><fpage>10</fpage><lpage>18</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Андреева Е.В., Мироманова Н.А., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Андреева Е.В., Мироманова Н.А.</copyright-holder><copyright-holder xml:lang="en">Andreeva E.V., Miromanova N.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.zabmedvestnik.ru/jour/article/view/519">https://www.zabmedvestnik.ru/jour/article/view/519</self-uri><abstract><p>Цель исследования. Оценить диагностическую и прогностическую значимость нейтрофильнолимфоцитарного соотношения (NLR) и тромбоцитарно-лимфоцитарного соотношения (PLR) для прогнозирования тяжести течения ротавирусного гастроэнтерита (РВГЭ) у детей. Материалы и методы. Проведено проспективное исследование с участием 45 детей с РВГЭ, разделенных на группы со среднетяжелым (n = 16) и тяжелым (n = 29) течением по шкале Везикари. Проводился расчет NLR и PLR при поступлении. Для статистического анализа использовались U-критерий Манна-Уитни, ROC-анализ и многофакторная логистическая регрессия. Результаты. Медианы NLR и PLR были достоверно выше в группе с тяжелым течением по сравнению со среднетяжелым: 4,26 [2,01–5,76] vs 1,64 [0,95–3,71] (p = 0,010) и 165,10 [122,69– 244,30] vs 84,79 [67,19–149,93] (p &lt; 0,001) соответственно. ROC-анализ показал хорошую диагностическую точность для прогноза тяжелой формы: площадь под кривой (AUC) для PLR составила 0,794 (95% ДИ: 0,655–0,945), для NLR – 0,750 (95% ДИ: 0,588–0,912). В многофакторном анализе независимым предиктором тяжелого течения остался только NLR (OR = 3,203; 95% ДИ: 1,293–7,939; p = 0,012). Заключение. NLR и PLR являются значимыми и доступными биомаркерами, ассоциированными с тяжестью течения ротавирусного гастроэнтерита у детей. NLR продемонстрировал свойства независимого прогностического фактора, что позволяет рекомендовать его использование для ранней стратификации риска и оптимизации терапии</p></abstract><trans-abstract xml:lang="en"><p>The aim of the research. To evaluate the diagnostic and prognostic significance of the neutrophil-tolymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) for predicting the severity of rotavirus gastroenteritis (RVGE) in children. Materials and methods. A prospective study was conducted involving 45 children with RVGE, stratified into groups with mild-to-moderate (n = 16) and severe (n = 29) disease according to the Vesikari scale. NLR and PLR were calculated upon admission. Statistical analysis included the Mann-Whitney U test, ROC analysis, and multivariate logistic regression. Results. The median NLR and PLR were significantly higher in the severe group compared to the mild-tomoderate group: 4,26 [2,01–5,76] vs 1,64 [0,95–3,71] (p = 0.010) and 165,10 [122,69–244,30] vs 84,79 [67,19–149,93] (p &lt; 0.001), respectively. ROC analysis demonstrated good diagnostic accuracy for predicting severe disease: the area under the curve (AUC) for PLR was 0,794 (95% CI: 0,655–0,945), and for NLR it was 0,750 (95% CI: 0,588–0,912). In the multivariate analysis, only NLR remained an independent predictor of severe course (OR = 3,203; 95% CI: 1,293–7,939; p = 0.012). Conclusion. NLR and PLR are significant and readily available biomarkers associated with the severity of rotavirus gastroenteritis in children. NLR demonstrated properties of an independent prognostic factor, supporting its use for early risk stratification and therapy optimization.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>ротавирусный гастроэнтерит</kwd><kwd>дети</kwd><kwd>нейтрофильно-лимфоцитарное соотношение (NLR)</kwd><kwd>тромбоцитарно-лимфоцитарное соотношение (PLR)</kwd><kwd>прогнозирование тяжести</kwd><kwd>биомаркеры</kwd><kwd>ROC-анализ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>rotavirus gastroenteritis</kwd><kwd>children</kwd><kwd>neutrophil-to-lymphocyte ratio (NLR)</kwd><kwd>platelet-to-lymphocyte ratio (PLR)</kwd><kwd>severity prediction</kwd><kwd>biomarkers</kwd><kwd>ROC analysis</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена в рамках государственного задания на научные исследования и разработки ФГБОУ ВО «Читинская государственная медицинская академия» Минздрава РФ.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Алагова М.В., Ермоленко К.Д. Клинико-эпидемиологическая характеристика острых гастроэнтеритов, вызванных ротавирусами различных генотипов, у детей (обзор литературы). Клиническая инфектология и паразитология. 2024; 13 (3): 403–414. doi:10.34883/PI.2024.13.3.041.</mixed-citation><mixed-citation xml:lang="en">Alagova M.V., Ermolenko K.D. Clinical and Epidemiological Characteristics of Acute Gastroenteritis Caused by Rotaviruses of Various Genotypes in Children (Literature Review). Clinical Infectology and Parasitology. 2024; 13 (3): 403–414. doi:10.34883/PI.2024.13.3.041. In Russian</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Bukhantsova E.S., Kovalev O.В., Shamsheva O.V., et al. Epidemiological and clinical significance of rotavirus infection during the vaccination period. Child Infect. 2024; 23 (4): 46–53. doi:10.22627/2072-8107-2024-23-4-46-53.</mixed-citation><mixed-citation xml:lang="en">Bukhantsova E.S., Kovalev O.В., Shamsheva O.V., et al. Epidemiological and clinical significance of rotavirus infection during the vaccination period. Child Infect. 2024; 23 (4): 46–53. doi:10.22627/2072-8107-2024-23-4-46-53.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Clark A., Mahmud S., Debellut F., et al. Estimating the global impact of rotavirus vaccines on child mortality. Int J Infect Dis. 2023; 137: 90–97. doi: 10.1016/j.ijid.2023.10.005.</mixed-citation><mixed-citation xml:lang="en">Clark A., Mahmud S., Debellut F., et al. Estimating the global impact of rotavirus vaccines on child mortality. Int J Infect Dis. 2023; 137: 90–97. doi: 10.1016/j.ijid.2023.10.005.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Okuyan O., Elgormus Y., Sayili U., et al. The Effect of Virus-Specific Vaccination on Laboratory Infection Markers of Children with Rotavirus-Associated Acute Gastroenteritis. Vaccines. 2023; 11 (3):580. doi:10.3390/vaccines11030580.</mixed-citation><mixed-citation xml:lang="en">Okuyan O., Elgormus Y., Sayili U., et al. The Effect of Virus-Specific Vaccination on Laboratory Infection Markers of Children with Rotavirus-Associated Acute Gastroenteritis. Vaccines. 2023; 11 (3):580. doi:10.3390/vaccines11030580.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Mwila-Kazimbaya K., Bosomprah S., Chilyabanyama O.N., et al. Association of biomarkers of enteric dysfunction, systemic inflammation, and growth hormone resistance with seroconversion to oral rotavirus vaccine: A lasso for inference approach. Kabir F, ed. PLOS ONE. 2023; 18 (11): e0293101. doi: 10.1371/journal.pone.0293101.</mixed-citation><mixed-citation xml:lang="en">Mwila-Kazimbaya K., Bosomprah S., Chilyabanyama O.N., et al. Association of biomarkers of enteric dysfunction, systemic inflammation, and growth hormone resistance with seroconversion to oral rotavirus vaccine: A lasso for inference approach. Kabir F, ed. PLOS ONE. 2023; 18 (11): e0293101. doi: 10.1371/journal.pone.0293101.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Demirtas M.S. Evaluation of Hemoglobin, Albumin, Lymphocyte, and Platelet Score, Neutrophil-toLymphocyte Ratio, and Platelet-to-Lymphocyte Ratio in Pediatric Patients with Rotavirus Enteritis. J Clin Pract Res. 2025; 47 (1): 28–35. doi:10.14744/cpr.2024.51648.</mixed-citation><mixed-citation xml:lang="en">Demirtas M.S. Evaluation of Hemoglobin, Albumin, Lymphocyte, and Platelet Score, Neutrophil-toLymphocyte Ratio, and Platelet-to-Lymphocyte Ratio in Pediatric Patients with Rotavirus Enteritis. J Clin Pract Res. 2025; 47 (1): 28–35. doi:10.14744/cpr.2024.51648.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Machura E., Krakowczyk H., Bąk-Drabik K., et al. SARS-CoV-2 Infection as a Possible Trigger for IgAAssociated Vasculitis: A Case Report. Children. 2023; 10 (2): 344. doi:10.3390/children10020344.</mixed-citation><mixed-citation xml:lang="en">Machura E., Krakowczyk H., Bąk-Drabik K., et al. SARS-CoV-2 Infection as a Possible Trigger for IgAAssociated Vasculitis: A Case Report. Children. 2023; 10 (2): 344. doi:10.3390/children10020344.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Liu X., Zhao Y., Mu Z., et al. The Combination of IL-6, PLR and Nail Psoriasis: Screen for the Early Diagnosis of Psoriatic Arthritis. Clin Cosmet Investig Dermatol. 2023; (16): 1703–1713. doi:10.2147/CCID.S413853.</mixed-citation><mixed-citation xml:lang="en">Liu X., Zhao Y., Mu Z., et al. The Combination of IL-6, PLR and Nail Psoriasis: Screen for the Early Diagnosis of Psoriatic Arthritis. Clin Cosmet Investig Dermatol. 2023; (16): 1703–1713. doi:10.2147/CCID.S413853.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Mukhin V.E., Pankratyeva L.L., Mileva O.I., et al. Absolute Neutropenia and Infection Development in Premature Infants in Early Neonatal Period: Cross-Sectional Study. Curr Pediatr. 2020; 19 (5): 352–358. doi:10.15690/vsp.v19i5.2211.</mixed-citation><mixed-citation xml:lang="en">Mukhin V.E., Pankratyeva L.L., Mileva O.I., et al. Absolute Neutropenia and Infection Development in Premature Infants in Early Neonatal Period: Cross-Sectional Study. Curr Pediatr. 2020; 19 (5): 352–358. doi:10.15690/vsp.v19i5.2211.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Sarkisian N.S., Kulichenko A.N. Significance of hematological blood markers in brucellosis (review of literature). Russ Clin Lab Diagn. 2023; 68 (1): 36–40. doi:10.51620/0869-2084-2023-68-1-36-40.</mixed-citation><mixed-citation xml:lang="en">Sarkisian N.S., Kulichenko A.N. Significance of hematological blood markers in brucellosis (review of literature). Russ Clin Lab Diagn. 2023; 68 (1): 36–40. doi:10.51620/0869-2084-2023-68-1-36-40.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Slesareva T.A., Gruzdeva O.V., Tarasova O.L., et al. The use of 8-diff clinical blood testing of patients to assess the severity of the new coronavirus infection. Sib J Clin Exp Med. 2023; 37 (4): 149–160. doi:10.29001/2073-8552-2022-37-4-149-160.</mixed-citation><mixed-citation xml:lang="en">Slesareva T.A., Gruzdeva O.V., Tarasova O.L., et al. The use of 8-diff clinical blood testing of patients to assess the severity of the new coronavirus infection. Sib J Clin Exp Med. 2023; 37 (4): 149–160. doi:10.29001/2073-8552-2022-37-4-149-160.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
